Search research articles
Contact Us
Filters
Showing results (61-70 of 85) with videos related to
Page
of 9
Sort By:
British Journal of Haematology
|
June 8, 2017
Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT)
Johannes Schetelig, Liesbeth C de Wreede, Niels S Andersen, et al.
British Journal of Haematology
|
February 29, 2020
Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT
Donal P McLornan, Vittoria Malpassuti, Anne Lippinkhof-Kozijn, et al.
Bone Marrow Transplantation
|
July 26, 2020
Upfront stem cell transplantation for newly diagnosed multiple myeloma with del(17p) and t(4;14): a study from the CMWP-EBMT
Nico Gagelmann, Diderik-Jan Eikema, Liesbeth C de Wreede, et al.
Bone Marrow Transplantation
|
May 13, 2024
Correction: Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT
Marie Robin, Simona Iacobelli, Linda Koster, et al.
NEJM Evidence
|
April 28, 2026
Clonal Dynamics of Hematopoiesis in Aplastic Anemia after Immunosuppression and Eltrombopag
Deniz Ece Kaya, Riley Cook, Simona Iacobelli, et al.
Clinical Immunology (Orlando, Fla.)
|
September 22, 2020
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy
Dimitrios C Mastellos, Bruno G P Pires da Silva, Benedito A L Fonseca, et al.
Haematologica
|
June 30, 2022
Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modeling
Sarah Lawless, Simona Iacobelli, Nina Simone Knelange, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 23, 2021
IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study
Sarah Lawless, Giulia Sbianchi, Curly Morris, et al.
Haematologica
|
April 6, 2006
The effect of prior exposure to imatinib on transplant-related mortality
Michael Deininger, Michael Schleuning, Hilde Greinix, et al.
Haematologica
|
April 22, 2017
Salvage use of allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorders subcommittee of the European Group for Blood and Marrow Transplant Chronic Malignancies Working Party
Mohamad Sobh, Mauricette Michallet, Valérie Dubois, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 85) with videos related to
Sort By:
Page
of 9
British Journal of Haematology
|
June 8, 2017
Centre characteristics and procedure-related factors have an impact on outcomes of allogeneic transplantation for patients with CLL: a retrospective analysis from the European Society for Blood and Marrow Transplantation (EBMT)
Johannes Schetelig, Liesbeth C de Wreede, Niels S Andersen, et al.
British Journal of Haematology
|
February 29, 2020
Outcome of allogeneic haematopoietic stem cell transplantation in myeloproliferative neoplasm, unclassifiable: a retrospective study by the Chronic Malignancies Working Party of the EBMT
Donal P McLornan, Vittoria Malpassuti, Anne Lippinkhof-Kozijn, et al.
Bone Marrow Transplantation
|
July 26, 2020
Upfront stem cell transplantation for newly diagnosed multiple myeloma with del(17p) and t(4;14): a study from the CMWP-EBMT
Nico Gagelmann, Diderik-Jan Eikema, Liesbeth C de Wreede, et al.
Bone Marrow Transplantation
|
May 13, 2024
Correction: Treosulfan compared to busulfan in allogeneic haematopoietic stem cell transplantation for myelofibrosis: a registry-based study from the Chronic Malignancies Working Party of the EBMT
Marie Robin, Simona Iacobelli, Linda Koster, et al.
NEJM Evidence
|
April 28, 2026
Clonal Dynamics of Hematopoiesis in Aplastic Anemia after Immunosuppression and Eltrombopag
Deniz Ece Kaya, Riley Cook, Simona Iacobelli, et al.
Clinical Immunology (Orlando, Fla.)
|
September 22, 2020
Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy
Dimitrios C Mastellos, Bruno G P Pires da Silva, Benedito A L Fonseca, et al.
Haematologica
|
June 30, 2022
Comparison of autologous and allogeneic hematopoietic cell transplantation strategies in patients with primary plasma cell leukemia, with dynamic prediction modeling
Sarah Lawless, Simona Iacobelli, Nina Simone Knelange, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
June 23, 2021
IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study
Sarah Lawless, Giulia Sbianchi, Curly Morris, et al.
Haematologica
|
April 6, 2006
The effect of prior exposure to imatinib on transplant-related mortality
Michael Deininger, Michael Schleuning, Hilde Greinix, et al.
Haematologica
|
April 22, 2017
Salvage use of allogeneic hematopoietic stem cell transplantation after reduced intensity conditioning from unrelated donors in multiple myeloma. A study by the Plasma Cell Disorders subcommittee of the European Group for Blood and Marrow Transplant Chronic Malignancies Working Party
Mohamad Sobh, Mauricette Michallet, Valérie Dubois, et al.
Page
of 9